4

OWNERSHIP DOCUMENT

Company: Ultragenyx Pharmaceutical Inc.
Filed: July 14, 2014
Period of Report: July 14, 2014
Accession Number: 0000903423-14-000419

View Document ↗ View on SEC.gov ↗